Bicisate (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the Bicisate drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: Bicisate
SUBSTANCE NAME: BICISATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00


Bicisate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBicisate from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1.35(mg/1)
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-217_b780bd14-67f7-4dd6-8d36-f53a6d38152c
PRODUCT NDC: 51808-217
APPLICATION NUMBER:

Other BICISATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationBicisate